Prognostic value of circulating tumor DNA in treated gastric cancer patients: A systematic review and meta-analysis.
BACKGROUND Multiple studies have demonstrated that circulating tumor DNA (ctDNA), a component of liquid biopsy, exhibits strong performance in predicting prognosis across various types of tumors. However, its role in predicting prognosis among gastric cancer patients undergoing treatment remains inconclusive. Therefore...